Metabolites
Displaying metabolites 1551 - 1575 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB01163 | Guanosine diphosphate mannose 3123-67-9 | [({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | 605.3411 C16H25N5O16P2 | ||
ECMDB21593 | PE(10:0/16:1(9Z)) | (2-aminoethoxy)[(2R)-3-(decanoyloxy)-2-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(10:0/16:1(9Z)) II PW001828 | 605.7838 C31H60NO8P | |
ECMDB21620 | PE(16:1(9Z)/10:0) | (2-aminoethoxy)[(2R)-2-(decanoyloxy)-3-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid | phospholipid biosynthesis (CL(16:1(9Z)/10:0/14:0/14:0)) PW001954 | 605.7838 C31H60NO8P | |
ECMDB24799 | DG(16:1(9Z)/19:0cycv8c/0:0) | (2R)-3-{[10-(2-hexylcyclopropyl)decanoyl]oxy}-2-hydroxypropyl (9Z)-hexadec-9-enoate | phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/16:1(9Z)/19:0cycv8c) PW001192 | 606.973 C38H70O5 | |
ECMDB24800 | DG(16:1(9Z)/19:0cycw8c/0:0) | (2R)-3-{[9-(2-heptylcyclopropyl)nonanoyl]oxy}-2-hydroxypropyl (9Z)-hexadec-9-enoate | phospholipid biosynthesis CL(16:0/16:0/16:1(9Z)/19:0cycv8c) PW001269 | 606.973 C38H70O5 | |
ECMDB24810 | DG(17:0cycw7c/18:1(9Z)/0:0) | (2R)-3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl (9Z)-octadec-9-enoate | phospholipid biosynthesis (CL(17:0cycw7c/18:1(9Z)/18:1(9Z)/14:0)) PW001473 | 606.973 C38H70O5 | |
ECMDB24815 | DG(18:1(9Z)/17:0cycw7c/0:0) | (2S)-3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl (9Z)-octadec-9-enoate | phospholipid biosynthesis (CL(18:1(9Z)/16:1(9Z)/18:1(9Z)/17:0cycw7c)) PW002014 | 606.973 C38H70O5 | |
ECMDB24822 | DG(19:0cycv8c/16:1(9Z)/0:0) | (2S)-3-{[10-(2-hexylcyclopropyl)decanoyl]oxy}-2-hydroxypropyl (9Z)-hexadec-9-enoate | 606.973 C38H70O5 | ||
ECMDB23294 | DG(16:1(9Z)/19:1(9Z)/0:0) | (2S)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropyl (9Z)-nonadec-9-enoate | phospholipid biosynthesis (PE(16:1(9Z)/19:iso)) PW001760 | 606.973 C38H70O5 | |
ECMDB23318 | DG(19:1(9Z)/16:1(9Z)/0:0) | (2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropyl (9Z)-nonadec-9-enoate | phospholipid biosynthesis (CL(19:1(9Z)/16:1(9Z)/19:1(9Z)/16:1(9Z))) PW001995 | 606.973 C38H70O5 | |
ECMDB00290 | Uridine diphosphate-N-acetylglucosamine 528-04-1 | [({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | Lipopolysaccharide biosynthesis PW000831 Amino sugar and nucleotide sugar metabolism I PW000886 Secondary Metabolites: enterobacterial common antigen biosynthesis PW000959 peptidoglycan biosynthesis I PW000906 More...lipopolysaccharide biosynthesis II PW001905 1,6-anhydro-N-acetylmuramic acid recycling PW002064 Secondary Metabolites: enterobacterial common antigen biosynthesis 2 PW002045 Secondary Metabolites: enterobacterial common antigen biosynthesis 3 PW002046 lipopolysaccharide biosynthesis III PW002059 peptidoglycan biosynthesis I 2 PW002062 O-antigen building blocks biosynthesis PW002089 | 607.3537 C17H27N3O17P2 | |
ECMDB20202 | UDP-N-Acetyl-D-mannosamine 26575-17-7 | N-[(3S,4R,5S,6R)-2-({[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid | Amino sugar and nucleotide sugar metabolism I PW000886 | 607.3537 C17H27N3O17P2 | |
ECMDB23446 | PE(10:0(3-OH)/15:0cyclo) | (2-aminoethoxy)[(2R)-2-{[8-(2-butylcyclopropyl)octanoyl]oxy}-3-[(3-hydroxydecanoyl)oxy]propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(10:0/15:0) II PW001826 | 607.7566 C30H58NO9P | |
ECMDB23497 | PE(15:0cyclo/10:0(3-OH)) | (2-aminoethoxy)[(2R)-3-{[8-(2-butylcyclopropyl)octanoyl]oxy}-2-[(3-hydroxydecanoyl)oxy]propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(15:0/10:0) II PW001859 | 607.7566 C30H58NO9P | |
ECMDB21592 | PE(10:0/16:0) | (2-aminoethoxy)[(2R)-3-(decanoyloxy)-2-(hexadecanoyloxy)propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(10:0/16:0) II PW001827 | 607.7996 C31H62NO8P | |
ECMDB21601 | PE(12:0/14:0) | (2-aminoethoxy)[(2R)-3-(dodecanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(12:0/14:0) PW001768 | 607.7996 C31H62NO8P | |
ECMDB21611 | PE(14:0/12:0) | (2-aminoethoxy)[(2R)-2-(dodecanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(14:0/12:0) IV PW001853 | 607.7996 C31H62NO8P | |
ECMDB21616 | PE(16:0/10:0) | (2-aminoethoxy)[(2R)-2-(decanoyloxy)-3-(hexadecanoyloxy)propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(16:0/10:0) PW001814 | 607.7996 C31H62NO8P | |
ECMDB24337 | DG(16:1(9Z)/0:0/19:0) | (2R)-1-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropan-2-yl nonadecanoate | 608.989 C38H72O5 | ||
ECMDB24338 | DG(16:1(9Z)/19:0/0:0) | (2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropyl nonadecanoate | phospholipid biosynthesis CL(16:1(9Z)/19:0cycv8c/14:0/16:1(9Z)) PW001616 | 608.989 C38H72O5 | |
ECMDB24346 | DG(18:1(11Z)/17:0/0:0) | (2R)-3-(heptadecanoyloxy)-2-hydroxypropyl (11Z)-octadec-11-enoate | phospholipid biosynthesis (CL(18:1(11Z)/17:0/14:0/14:0)) PW001978 | 608.989 C38H72O5 | |
ECMDB24349 | DG(19:0/0:0/16:1(9Z)) | (2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropyl nonadecanoate | 608.989 C38H72O5 | ||
ECMDB24351 | DG(19:0/16:1(9Z)/0:0) | (2S)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropyl nonadecanoate | 608.989 C38H72O5 | ||
ECMDB24795 | DG(16:0/19:0cycv8c/0:0) | (2S)-3-{[10-(2-hexylcyclopropyl)decanoyl]oxy}-2-hydroxypropyl hexadecanoate | phospholipid biosynthesis CL(16:0/16:0/16:0/19:0cycv8c) PW001259 | 608.989 C38H72O5 | |
ECMDB24796 | DG(16:0/19:0cycw8c/0:0) | (2S)-3-{[9-(2-heptylcyclopropyl)nonanoyl]oxy}-2-hydroxypropyl hexadecanoate | phospholipid biosynthesis CL(16:0/18:1(9Z)/16:0/19:0cycv8c) PW001361 | 608.989 C38H72O5 |